Frequency of mitogen-activated protein kinase and phosphoinositide 3-kinase signaling pathway pathogenic alterations in EUS-FNA sampled malignant lymph nodes in rectal cancer with theranostic potential.

MLA

Gleeson, Ferga C., et al. “Frequency of Mitogen-Activated Protein Kinase and Phosphoinositide 3-Kinase Signaling Pathway Pathogenic Alterations in EUS-FNA Sampled Malignant Lymph Nodes in Rectal Cancer with Theranostic Potential.” Gastrointestinal Endoscopy, vol. 82, no. 3, Sept. 2015, p. 550–556.e1. EBSCOhost, https://doi.org/10.1016/j.gie.2015.01.050.

APA

Gleeson, F. C., Kipp, B. R., Voss, J. S., Campion, M. B., Minot, D. M., Tu, Z. J., Klee, E. W., Graham, R. P., Lazaridis, K. N., Henry, M. R., & Levy, M. J. (2015). Frequency of mitogen-activated protein kinase and phosphoinositide 3-kinase signaling pathway pathogenic alterations in EUS-FNA sampled malignant lymph nodes in rectal cancer with theranostic potential. Gastrointestinal Endoscopy, 82(3), 550–556.e1. https://doi.org/10.1016/j.gie.2015.01.050

Chicago

Gleeson, Ferga C., Benjamin R. Kipp, Jesse S. Voss, Michael B. Campion, Douglas M. Minot, Zheng J. Tu, Eric W. Klee, et al. 2015. “Frequency of Mitogen-Activated Protein Kinase and Phosphoinositide 3-Kinase Signaling Pathway Pathogenic Alterations in EUS-FNA Sampled Malignant Lymph Nodes in Rectal Cancer with Theranostic Potential.” Gastrointestinal Endoscopy 82 (3): 550–556.e1. doi:10.1016/j.gie.2015.01.050.